Which laboratory tests should be obtained to evaluate hives of unknown origin?

Laboratory Testing for Hives of Unknown Origin

For chronic spontaneous urticaria (hives lasting >6 weeks), the 2022 international guidelines recommend only very limited routine laboratory testing, with extensive workup reserved for cases where history and physical examination suggest specific underlying conditions. 11

Initial Approach: History-Directed Testing Only

The most recent guidelines emphasize that no routine laboratory testing is recommended unless the patient's history suggests a specific underlying cause 1. This represents a significant departure from older practices of extensive laboratory workups.

Key Historical Red Flags That Trigger Specific Testing:

If wheals last >24 hours at one site:

• Skin biopsy to evaluate for urticarial vasculitis (look for vessel damage, fibrinoid deposits) 1
• Consider C-reactive protein and erythrocyte sedimentation rate 1

If angioedema without wheals or with prominent angioedema:

• Complement C4 level
• C1-inhibitor (C1-INH) levels and function
• If acquired angioedema suspected: C1q and C1-INH antibodies 1

If fever, joint/bone pain, or malaise present:

• C-reactive protein and erythrocyte sedimentation rate
• Consider paraproteinemia testing in adults
• Gene mutation analysis for hereditary periodic fever syndromes if strongly suspected 1

If taking ACE inhibitors or ARBs:

• No labs needed—trial discontinuation for days to 6 months 1

For Typical Chronic Spontaneous Urticaria (CSU)

The guideline explicitly states that routine extensive laboratory testing is NOT recommended for straightforward CSU cases 1. The diagnostic workup should focus on:

1. Detailed history and physical examination (looking for duration of individual wheals, triggers, medication history)
2. Urticaria Control Test (UCT) to assess disease control 11
3. 7-Day Urticaria Activity Score (UAS7) to quantify severity 1

When to Consider Additional Testing in CSU:

Only pursue further workup if looking for:

• Cofactors and triggers based on specific clinical suspicion
• Comorbidities like chronic inducible urticaria or autoimmune thyroiditis (if clinically indicated)
• Autoimmune markers only if considering type I or IIb autoimmune CSU and planning specific treatment 1

Common Pitfalls to Avoid:

• Do not order extensive "urticaria panels" without clinical indication—this leads to false positives and unnecessary anxiety 2
• Do not routinely test for allergies in chronic urticaria; it is rarely allergic in nature 1
• Do not assume all hive-like rashes are urticaria—if lesions persist >24-36 hours at one site or don't respond to antihistamines, biopsy to exclude other inflammatory processes 3
• Remember that systematic reviews found no relationship between the number of laboratory tests performed and the number of identified diagnoses 2

Acute Urticaria (<6 weeks)

For acute urticaria, no routine testing is recommended unless history suggests a specific allergic cause requiring confirmation 1. Most acute urticaria is self-limited and responds to antihistamines alone 4.